Qc Counselor Plc - Medicare Mental Health Clinic in Davenport, IA

Qc Counselor Plc is a medicare enrolled mental health clinic (Counselor - Mental Health) in Davenport, Iowa. The current practice location for Qc Counselor Plc is 2028 E 38th St Ste 3, Davenport, Iowa. For appointments, you can reach them via phone at (563) 424-2016. The mailing address for Qc Counselor Plc is 2028 E 38th St, Suite 3, Davenport, Iowa and phone number is (563) 424-2016.

Qc Counselor Plc is licensed to practice in Iowa (license number 00728). The clinic also participates in the medicare program and its NPI number is 1285919977. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (563) 424-2016.

Contact Information

Qc Counselor Plc
2028 E 38th St Ste 3
Davenport
IA 52807-1168
(563) 424-2016
(563) 424-2017

Mental Health Clinic Profile

Full NameQc Counselor Plc
SpecialityCounselor
Location2028 E 38th St Ste 3, Davenport, Iowa
Authorized Official Name and PositionMatthew John Martenson (OWNER)
Authorized Official Contact5634242016
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Qc Counselor Plc
2028 E 38th St
Suite 3
Davenport
IA 52807-1168

Ph: (563) 424-2016
Qc Counselor Plc
2028 E 38th St Ste 3
Davenport
IA 52807-1168

Ph: (563) 424-2016

NPI Details:

NPI Number1285919977
Provider Enumeration Date10/13/2011
Last Update Date12/28/2023
Certification Date12/28/2023

Medicare PECOS Information:

Medicare PECOS PAC ID9537510730
Medicare Enrollment IDO20240112000654

News Archive

Lexicon announces results from two initial trials of LX4211 for type 2 diabetes

Lexicon Pharmaceuticals, Inc. announced today the publication of results from two initial trials of LX4211 in patients with type 2 diabetes in the online edition of the journal Clinical Pharmacology & Therapeutics.

Soligenix first quarter revenues decrease to $647,418

Soligenix, Inc., a development stage biopharmaceutical company, announced today its financial results for the quarter ending March 31, 2012.

Tonix to initiate TNX-102 PK and BA study for fibromyalgia

Tonix Pharmaceuticals Holding Corp., a specialty pharmaceutical company developing therapies for challenging disorders of the central nervous system, including fibromyalgia syndrome and post-traumatic stress disorder, will initiate a comparative pharmacokinetic and bioavailability study of TNX-102, a novel dosage oral formulation of cyclobenzaprine for the treatment of FM, following the U.S. Food and Drug Administration clearance of the Company's initial Investigational New Drug Application.

Inovio Biomedical reports financial results for the three and nine months ended September 30, 2009

Inovio Biomedical Corporation today reported financial results for the three and nine months ended September 30, 2009.

Read more Medical News

› Verified 5 days ago

Medical Identifiers

Medical identifiers for Qc Counselor Plc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1285919977NPI-NPPES
11087500000MedicaidIA
1285919977MedicaidIA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
101YM0800XCounselor - Mental Health 00728 (Iowa)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Qc Counselor Plc acts as a billing entity for following providers:
Provider NameMatthew John Martenson
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1275088114
PECOS PAC ID: 0446601645
Enrollment ID: I20240112001104

News Archive

Lexicon announces results from two initial trials of LX4211 for type 2 diabetes

Lexicon Pharmaceuticals, Inc. announced today the publication of results from two initial trials of LX4211 in patients with type 2 diabetes in the online edition of the journal Clinical Pharmacology & Therapeutics.

Soligenix first quarter revenues decrease to $647,418

Soligenix, Inc., a development stage biopharmaceutical company, announced today its financial results for the quarter ending March 31, 2012.

Tonix to initiate TNX-102 PK and BA study for fibromyalgia

Tonix Pharmaceuticals Holding Corp., a specialty pharmaceutical company developing therapies for challenging disorders of the central nervous system, including fibromyalgia syndrome and post-traumatic stress disorder, will initiate a comparative pharmacokinetic and bioavailability study of TNX-102, a novel dosage oral formulation of cyclobenzaprine for the treatment of FM, following the U.S. Food and Drug Administration clearance of the Company's initial Investigational New Drug Application.

Inovio Biomedical reports financial results for the three and nine months ended September 30, 2009

Inovio Biomedical Corporation today reported financial results for the three and nine months ended September 30, 2009.

Read more Medical News

› Verified 5 days ago

Provider NameMollie Ann Schmelzer
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1700138120
PECOS PAC ID: 8426400664
Enrollment ID: I20240123003977

News Archive

Lexicon announces results from two initial trials of LX4211 for type 2 diabetes

Lexicon Pharmaceuticals, Inc. announced today the publication of results from two initial trials of LX4211 in patients with type 2 diabetes in the online edition of the journal Clinical Pharmacology & Therapeutics.

Soligenix first quarter revenues decrease to $647,418

Soligenix, Inc., a development stage biopharmaceutical company, announced today its financial results for the quarter ending March 31, 2012.

Tonix to initiate TNX-102 PK and BA study for fibromyalgia

Tonix Pharmaceuticals Holding Corp., a specialty pharmaceutical company developing therapies for challenging disorders of the central nervous system, including fibromyalgia syndrome and post-traumatic stress disorder, will initiate a comparative pharmacokinetic and bioavailability study of TNX-102, a novel dosage oral formulation of cyclobenzaprine for the treatment of FM, following the U.S. Food and Drug Administration clearance of the Company's initial Investigational New Drug Application.

Inovio Biomedical reports financial results for the three and nine months ended September 30, 2009

Inovio Biomedical Corporation today reported financial results for the three and nine months ended September 30, 2009.

Read more Medical News

› Verified 5 days ago

News Archive

Lexicon announces results from two initial trials of LX4211 for type 2 diabetes

Lexicon Pharmaceuticals, Inc. announced today the publication of results from two initial trials of LX4211 in patients with type 2 diabetes in the online edition of the journal Clinical Pharmacology & Therapeutics.

Soligenix first quarter revenues decrease to $647,418

Soligenix, Inc., a development stage biopharmaceutical company, announced today its financial results for the quarter ending March 31, 2012.

Tonix to initiate TNX-102 PK and BA study for fibromyalgia

Tonix Pharmaceuticals Holding Corp., a specialty pharmaceutical company developing therapies for challenging disorders of the central nervous system, including fibromyalgia syndrome and post-traumatic stress disorder, will initiate a comparative pharmacokinetic and bioavailability study of TNX-102, a novel dosage oral formulation of cyclobenzaprine for the treatment of FM, following the U.S. Food and Drug Administration clearance of the Company's initial Investigational New Drug Application.

Inovio Biomedical reports financial results for the three and nine months ended September 30, 2009

Inovio Biomedical Corporation today reported financial results for the three and nine months ended September 30, 2009.

Read more News

› Verified 5 days ago

Counselor in Davenport, IA

Courageous Aim Llc
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 2805 Eastern Ave Ste D, Davenport, IA 52803
Phone: 563-505-0141    
Vera French Community Mental Health
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1441 W Central Park Ave, Davenport, IA 52804
Phone: 563-383-1900    Fax: 563-328-5690
Hope For Tomorrow Therapy Services, Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1140 E Kimberly Rd Ste 110, Davenport, IA 52807
Phone: 563-200-3154    Fax: 833-228-5356
Ciaccio Medical, P.c.
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1401 W Central Park Ave, Davenport, IA 52804
Phone: 309-236-8075    
The Robert Young Center For Community Mental Health
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 12160 S Utah Ave, Davenport, IA 52804
Phone: 563-326-1150    
Revolution Counseling Services Llc
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 601 Brady St Ste 204, Davenport, IA 52803
Phone: 309-781-4053    Fax: 309-792-2440
Bhg Lxxxvi, Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 3811 North Harrison Street, Obot Room #100, Davenport, IA 52806
Phone: 563-388-8000    Fax: 563-388-8002

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.